86
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An updated overview of e-cigarette impact on human health

      review-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The electronic cigarette ( e-cigarette), for many considered as a safe alternative to conventional cigarettes, has revolutionised the tobacco industry in the last decades. In e-cigarettes, tobacco combustion is replaced by e-liquid heating, leading some manufacturers to propose that e-cigarettes have less harmful respiratory effects than tobacco consumption. Other innovative features such as the adjustment of nicotine content and the choice of pleasant flavours have won over many users. Nevertheless, the safety of e-cigarette consumption and its potential as a smoking cessation method remain controversial due to limited evidence. Moreover, it has been reported that the heating process itself can lead to the formation of new decomposition compounds of questionable toxicity. Numerous in vivo and in vitro studies have been performed to better understand the impact of these new inhalable compounds on human health. Results of toxicological analyses suggest that e-cigarettes can be safer than conventional cigarettes, although harmful effects from short-term e-cigarette use have been described. Worryingly, the potential long-term effects of e-cigarette consumption have been scarcely investigated. In this review, we take stock of the main findings in this field and their consequences for human health including coronavirus disease 2019 (COVID-19).

          Related collections

          Most cited references110

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

          Structure of the nCoV trimeric spike The World Health Organization has declared the outbreak of a novel coronavirus (2019-nCoV) to be a public health emergency of international concern. The virus binds to host cells through its trimeric spike glycoprotein, making this protein a key target for potential therapies and diagnostics. Wrapp et al. determined a 3.5-angstrom-resolution structure of the 2019-nCoV trimeric spike protein by cryo–electron microscopy. Using biophysical assays, the authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor. They also tested three antibodies known to bind to the SARS-CoV spike protein but did not detect binding to the 2019-nCoV spike protein. These studies provide valuable information to guide the development of medical counter-measures for 2019-nCoV. Science, this issue p. 1260
            • Record: found
            • Abstract: found
            • Article: not found

            A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy

            E-cigarettes are commonly used in attempts to stop smoking, but evidence is limited regarding their effectiveness as compared with that of nicotine products approved as smoking-cessation treatments.
              • Record: found
              • Abstract: found
              • Article: not found

              e-Cigarette Use Among Youth in the United States, 2019

              The prevalence of e-cigarette use among US youth increased from 2011 to 2018. Continued monitoring of the prevalence of e-cigarette and other tobacco product use among youth is important to inform public health policy, planning, and regulatory efforts.

                Author and article information

                Contributors
                maria.j.sanz@uv.es
                Journal
                Respir Res
                Respir Res
                Respiratory Research
                BioMed Central (London )
                1465-9921
                1465-993X
                18 May 2021
                18 May 2021
                2021
                : 22
                : 151
                Affiliations
                [1 ]GRID grid.5338.d, ISNI 0000 0001 2173 938X, Department of Pharmacology, Faculty of Medicine, , University of Valencia, ; Avda. Blasco Ibañez 15, 46010 Valencia, Spain
                [2 ]Institute of Health Research INCLIVA, University Clinic Hospital of Valencia, Valencia, Spain
                [3 ]GRID grid.413448.e, ISNI 0000 0000 9314 1427, CIBERDEM-Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, ISCIII, ; Av. Monforte de Lemos 3-5, 28029 Madrid, Spain
                Author information
                http://orcid.org/0000-0003-0465-1727
                http://orcid.org/0000-0001-8010-5168
                http://orcid.org/0000-0002-8885-294X
                Article
                1737
                10.1186/s12931-021-01737-5
                8129966
                34006276
                075478ce-df1f-4181-9abc-5e30ddaaf4f6
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 22 October 2020
                : 3 May 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100014440, Ministerio de Ciencia, Innovación y Universidades;
                Award ID: SAF2017-89714-R
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004587, Instituto de Salud Carlos III;
                Award ID: PI18/00209
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100011596, Conselleria d'Educació, Investigació, Cultura i Esport;
                Award ID: PROMETEO/2019/032
                Award ID: Gent T CDEI-04/20-A
                Award Recipient :
                Categories
                Review
                Custom metadata
                © The Author(s) 2021

                Respiratory medicine
                electronic cigarette,e-cigarette,nicotine,tobacco,humectants,flavourings,toxicity,smoking cessation tool,covid-19

                Comments

                Comment on this article

                Related Documents Log